Report Id: SNS/HC/1290 | May 2022 | Region: Global | 125 Pages
Report Scope & Overview:
The Analgesics Market was esteemed at USD 29.44 billion out of 2022, and expected to arrive at USD 48 billion by 2030, and develop at a CAGR of 6.3% over the conjecture period 2023-2030.
Analgesics, often known as painkillers, are medications that are used to treat and alleviate pain. They're utilized when a patient's discomfort is overwhelming. The most often used topical analgesics worldwide are non-opioids, opioids, and compound analgesics (a combination of opioids and non-opioids). The most powerful painkillers are opioid medicines, which are made from opium. They're only provided with a prescription and are typically used to treat moderate to severe pain. Non-opioid drugs, on the other hand, contain acetaminophen rather than opium. NSAIDs (non-steroidal anti-inflammatory medicines) are another form of pain reliever.
In a variety of clinical contexts for mild to severe acute and chronic pain, they are fast being advocated as a desirable, safe, and effective first-line treatment alternative to opioid medications. Prescribed analgesics, over-the-counter analgesics, and oral, intravenous, rectal, transdermal, and topical analgesics are among the several types of medications.
Pain from physiological injuries, operations, phantom aches, inflammation, neuropathic diseases, and cancer treatments are all treated with analgesics. With increasing internet penetration, several e-commerce platforms are now collaborating with pharmaceutical firms to deliver pharmaceuticals such as analgesics to consumers' homes.
Increased Cases of Cardiovascular Disease, Cancer, and Arthritis
Increased Geriatric Population
Healthcare Initiatives by the Government
Advancement in treatment
The availability of well-known healthcare facilities
Opioid abuse is illegal.
In emerging nations, the medical services area is growing.
Research and development spending is increasing.
Analgesic Drugs' Side Effects
IMPACT OF COVID-19
The COVID-19 epidemic had an influence on the global analgesics industry. The epidemic benefited the market because heightened attention to personal health boosted the purchasing of these treatments. COVID-19 was expected to increase demand for over-the-counter cold and cough treatments, as well as nutritional supplements, which were already in high demand. Moreover, the European Medicines Agency recommends using non-steroidal anti-inflammatories (NSAIDs) such ibuprofen and paracetamol at the lowest possible dose possible to treat moderate COVID-19 symptoms. Furthermore, because geriatrics are more susceptible to infection due to weakened immune systems and the lack of a vaccine or treatment, the number of older people infected with COVID-19 was high. As a result, during the epidemic, all of these causes raised the need for analgesics.
Due to the widespread use of non-opioid analgesics for pain relief, as well as lower adverse effects and government and private-sector initiatives to promote the use of non-opioids drugs as a painkiller, the non-opioids drugs segment was the leading contributor in 2021 and is expected to remain so throughout the forecast period. Because opioids contain analgesic, anti-inflammatory, and antipyretic properties, the opioids medications segment is predicted to develop significantly during the forecast period. In addition, the opioid segment is predicted to develop due to an increase in the incidence of chronic diseases like tuberculosis (TB), cardiovascular disease, arthritis, and cancer over the forecast period.
By Route of Administration Type:
Due to the simple administration of analgesics by oral route, which is non-invasive in nature and effective when compared to other routes of administration, the oral administration segment dominated the market in 2020, and this pattern is supposed to go on during the anagesics market gauge period. Furthermore, the expansion of the oral administration segment is fueled by an increase in the number of FDA drug approvals in the United States and developments in pharmaceutical R&D activities. However, due to advancements in healthcare technology and an increase in the number of analgesics medications, the topical administration segment is likely to develop significantly throughout the projection period. Topical analgesics are applied to the skin over sore muscles or joints and massaged or sprayed on.
By Application type
Internal analgesics currently hold a significant market share. They are meant for internal usage and are either swallowed as pills or liquids, or put into the rectum as suppositories.
By Pain Type
Musculoskeletal pain currently accounts for the majority of the global market. An injury to the bones, joints, muscles, tendons, ligaments, or nerves is the most common cause.
By Drug type
Opioids are the most popular drugs on the market because they are commonly used to treat cancer pain and end-stage diseases that necessitate palliative care.
Some of the major key players are as follows: johnson and johnson md&d, Abbott Laboratories, Eli Lilly and Company, Bayer AG, endo pharmaceuticals, AbbVie Inc., Pfizer, Inc., Glaxosmithkline plc, Sanofi, Reckitt Benckiser Group, and other players.
By Drug type
By Route of Administration type
By Pain Type
Surgical and Trauma
Pain due to Burns
By Application type
Due to an increase in demand for non-opioids medications, the presence of important players, and the expansion of R&D activities in the healthcare sector in the area, North America dominated the analgesics market in 2020 and is likely to continue to do so during the forecast period. However, from 2022 to 2028, Asia-Pacific is expected to have the highest CAGR of 6.3 percent, owing to an increase in painkiller use, increased awareness about the use of analgesics drugs, increased healthcare expenditures, increased OTC analgesics market growth, and increased analgesics product adoption.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 29.44 Billion|
|Market Size by 2030||US$ 48 Billion|
|CAGR||CAGR of 6.3% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Opioids, Non opioids), By Drug type (NSAID, Opioids, Others)
• By Route of Administration type (Oral, Topical, Transdermal, Parenteral, Rectal)
• By Pain Type (Musculoskeletal, Migraine, Neuropathic, Obstetrical, Surgical and Trauma, Cancer, Fibromyalgia, Pain due to Burns)
• By Application (External, Internal)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||johnson and johnson md&d, Abbott Laboratories, Eli Lilly and Company, Bayer AG, endo pharmaceuticals, AbbVie Inc., Pfizer, Inc., Glaxosmithkline plc, Sanofi, Reckitt Benckiser Group, and other players.|
|DRIVERS||• Increased Cases of Cardiovascular Disease, Cancer, and Arthritis
• Increased Geriatric Population
• Healthcare Initiatives by the Government
|RESTRAINTS||• Opioid abuse is illegal.
• In emerging nations, the medical services area is growing.
Frequently Asked Questions (FAQ) :
Opioid abuse is illegal, and in emerging nations, the medical services area is growing is the restraints of the Analgesics market.
Analgesics Market is divided into four segments and they are By Type, By Drug type, By Route of Administration type, By Pain Type, and By Application type.
North America dominated the analgesics market.
Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Analgesics market is expected to grow at a CAGR of 6.3% over the forecast period 2022-2028.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces Model
7. PEST Analysis
8. Analgesics Market Segmentation, By Type
8.2 Non opioids
9. Analgesics Market Segmentation, By Drug type
10. Analgesics Market Segmentation, By Route of Administration type
11. Analgesics Market Segmentation, By Pain Type
11.5 Surgical and Trauma
11.8 Pain due to Burns
12. Analgesics Market Segmentation, By Application type
13. Regional Analysis
13.2 North America
13.3.6 The Netherlands
13.3.7 Rest of Europe
13.4.2 South Korea
13.4.6 Rest of Asia-Pacific
13.5 The Middle East & Africa
13.5.3 South Africa
13.6 Latin America
13.6.3 Rest of Latin America
14. Company Profiles
14.1 johnson and johnson md&d.
14.1.2 Products/ Services Offered
14.1.3 SWOT Analysis
14.1.4 The SNS view
14.2 Abbott Laboratories
14.3 Eli Lilly and Company
14.4 Bayer AG
14.5 endo pharmaceuticals
14.6 AbbVie Inc.
14.7 Pfizer, Inc.
14.8 Glaxosmithkline plc
14.10 Reckitt Benckiser Group.
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.